Clinical Trials Directory

Trials / Completed

CompletedNCT00133848

Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment

A Randomised, Double-blind, Multicentre, Superiority Placebo-controlled, Phase III Study to Assess the Efficacy and Safety of Topical 1% SB-275833 Ointment Versus Placebo Ointment Applied Twice Daily for 5 Days in the Treatment of Adults and Paediatric Subjects With Impetigo.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
210 (planned)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
9 Months
Healthy volunteers
Not accepted

Summary

The goal of this study is to determine if topical SB-275833 ointment, 1% is more effective than a placebo ointment in the treatment of primary impetigo.

Conditions

Interventions

TypeNameDescription
DRUGSB-275833 ointment, 1%

Timeline

Start date
2005-04-01
Completion
2006-01-01
First posted
2005-08-24
Last updated
2016-09-23

Locations

22 sites across 5 countries: India, Italy, Mexico, Netherlands, Peru

Source: ClinicalTrials.gov record NCT00133848. Inclusion in this directory is not an endorsement.